BioSpace News Archive

Protect Pharmaceutical Corporation, Inc. “OTC:(PRTT)” announces that after many months of strategic planning and development, the two companies are ready to announce the details of their upcoming merger.

T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the U.S. Patent and Trademark Office has issued patent number 11,326,213.

Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced two oral presentations on the atrasentan clinical program and Evotec collaboration at the 59th ERA Congress 2022 being held virtually and live in Paris, France.

Scientists from St. Jude Children’s Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell death pathway, PANoptosis, are major contributors to the negative effects of interferon treatment and high interferon levels in some COVID-19 patients.

The scientific and technological advancement have paved the way for several therapeutic antibodies in the management of cancer.

Biomea Fusion, Inc. announced that Biomea will attend the H.C. Wainwright Global Investment Conference virtually and will participate in 1x1 meetings held by the conference organizers.

The global diabetes therapeutics market was valued at $1,258.9 billion in 2020, and is projected to reach US$ 3,390 billion by 2030, growing at a CAGR of 10.4% from 2021 to 2030.

Viatris Inc., a global pharmaceutical company, announced the company will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, CA on Tuesday, June 14, 2022.

DUBAI, United Arab Emirates, The demand for antibiotics API will continue rising at a steady pace between 2021 and 2031.

Albany NY, United States: The global surgical sphincteroplasty market is projected to witness significant growth from 2021 to 2031.